Area | Treatment (number of subject) | Mean change of slopem (%) | Standard error | p Value |
---|---|---|---|---|
B | Placebo (12) | 7.979 | 33.164 | – |
B | Dorzolamide (5) | 14.302 | 25.999 | 0.9096 |
C | Placebo (11) | 41.396 | 44.319 | – |
C | Dorzolamide (5) | 4.197 | 21.919 | 0.5955 |
E | Placebo (12) | 21.851 | 23.163 | – |
E | Dorzolamide (5) | 21.801 | 20.996 | 0.9990 |
F | Placebo (11) | −2.833 | 29.368 | – |
F | Dorzolamide (5) | −7.984 | 29.368 | 0.9103 |
Total perifoveal area | Placebo (12) | 13.301 | 27.209 | – |
Total perifoveal area | Dorzolamide (5) | 8.079 | 7.241 | 0.9054 |